<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03802760</url>
  </required_header>
  <id_info>
    <org_study_id>2018-01066</org_study_id>
    <nct_id>NCT03802760</nct_id>
  </id_info>
  <brief_title>Cerebral Microembolism in Cardiology</brief_title>
  <acronym>ZEMEK</acronym>
  <official_title>Cerebral Microembolism in Interventional Cardiology Procedures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During different interventional cardiology procedures we aim to identify cerebral microemboli&#xD;
      load. Further we aim to differentiate the quality and the quantity of cerebral microemboli.We&#xD;
      will measure cerebral microemboli in different interventional phases, e.g. during valve&#xD;
      deployment, rapid pacing, post-implantation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 24, 2018</start_date>
  <completion_date type="Anticipated">June 24, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 24, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quality of cerebral microemboli (solid vs. gaseous)</measure>
    <time_frame>intraoperative phase, expected to be approx. 4 hours</time_frame>
    <description>The quality of cerebral microemboli is measured by Doppler ultrasonography which automatically detects and analyses the Doppler signal coming from the middle cerebral artery. According to the strength of signal reflection, the signal will be qualified as solid or gaseous.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantity of cerebral microemboli load</measure>
    <time_frame>intraoperative phase, expected to be approx. 4 hours</time_frame>
    <description>The quantity of cerebral microemboli is measured by Doppler ultrasonography which automatically register the counts of solid and gaseous emboli.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral hemispheric differences (left vs. right)</measure>
    <time_frame>intraoperative phase, expected to be approx. 4 hours</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cerebral Embolism</condition>
  <arm_group>
    <arm_group_label>TAVI patients</arm_group_label>
    <description>Patients undergoing transfemoral TAVI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MitraClip patients</arm_group_label>
    <description>Patients undergoing MitraClip implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TricuspidalClip</arm_group_label>
    <description>Patients undergoing TricuspidalClip implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Doppler (TCD) ultrasound measurement</intervention_name>
    <description>Non-invasive measurement of cerebral embolic load and blood flow using TCD</description>
    <arm_group_label>MitraClip patients</arm_group_label>
    <arm_group_label>TAVI patients</arm_group_label>
    <arm_group_label>TricuspidalClip</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing Interventional cardiology procedure (TAVI, MitraClip, TricuspidalClip)&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Interventional cardiology procedure (TAVI, MitraClip, TricuspidalClip)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to ultrasound gel or materials contained in the TCD probe&#xD;
&#xD;
          -  Missing temporal bone window&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Gabor Erdoes, MD</last_name>
    <phone>00416322726</phone>
    <email>gabor.erdoes@insel.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maximilian Pucklitzsch, MS</last_name>
    <email>maximilian.pucklitzsch@insel.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gabor Erdoes, MD PhD</last_name>
      <phone>0041316322726</phone>
      <email>gabor.erdoes@insel.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>January 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 14, 2019</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Inselspital, Berne</investigator_affiliation>
    <investigator_full_name>Gabor Erd√∂s</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Embolism</mesh_term>
    <mesh_term>Embolism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

